Results 71 to 80 of about 121,033 (200)

Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan

open access: yes, 2017
Hideaki Yoshimura, Masaaki Hotta, Takahisa Nakanishi, Shinya Fujita, Aya Nakaya, Atsushi Satake, Tomoki Ito, Kazuyoshi Ishii, Shosaku Nomura First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka ...
Ito T   +8 more
core  

Granulocyte colony-stimulating factor and other cytokines in antifungal therapy

open access: yes, 2001
Invasive fungal infections (IFIs) have emerged as a serious threat in immunocompromised patients during the last two decades. Host defenses including appropriate cytokine responses and intact phagocytic function are necessary to combat IFIs.
Farmaki, E., Roilides, E.
core   +1 more source

Recombinant granulocyte colony stimulating factor biosimilars. Quality assessment

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2018
The article describes general principles of evidence-based quality assessment research of a recombinant granulocyte colony stimulating factor preparation (G-CSF) under development as well as a confirmation of its similarity to reference preparation ...
Zh. I. Avdeeva   +9 more
doaj  

Effect of Increased Endometrial Thickness and Implantation Rate by Granulocyte Colony-Stimulating Factor on Unresponsive Thin Endometrium in Fresh In Vitro Fertilization Cycles: A Randomized Clinical Trial

open access: yesObstetrics and Gynecology International, 2017
Background. The correlation between endometrial thickness and receptivity has been mentioned in various studies. This study investigated the effect of granulocyte colony-stimulating factor in treating thin endometrium of infertile women who were chosen ...
Fatemeh Sarvi   +4 more
doaj   +1 more source

Granulocyte Colony-Stimulating Factor Does Not Promote Neurogenesis after Experimental Intracerebral Haemorrhage

open access: yes, 2017
Background Hematopoietic growth factors have been suggested to induce neuroprotective and regenerative effects in various animal models of cerebral injury. However, the pathways involved remain widely unexplored.
Schlachetzki, Johannes C.   +7 more
core   +1 more source

Augmentation of the immune response with granulocyte-macrophage colony-stimulating factor and other hematopoietic growth factors

open access: yes, 1999
Granulocyte-macrophage colony-stimulating factor is by far the most widely used hematopoietic growth factor to augment immune responses. At present, the best secured effect is as an adjuvant cytokine for vaccination.
Frödin, JE   +8 more
core   +1 more source

Capillary zone electrophoresis investigation of interactions between granulocyte-colony stimulating factor and dextran sulfate/carrageenan oligosaccharide

open access: yes, 2005
The interactions between granulocyte-colony stimulating factor (G-CSF) and dextran sulfate/kappa-carrageenan oligosaccharide were studied by capillary zone electrophoresis.
林炳承   +4 more
core  

Cutaneous manifestations of granulocyte colony-stimulating factor

open access: yes, 2006
Granulocyte colony-stimulating factor (GCSF) is a recombinant human growth factor widely used in haematology. It is known to cause cutaneous vasculitis and neutrophilic dermatoses. We present three cases of Sweet's syndrome (SS) associated with GCSF use.
Salisbury, J R   +3 more
core   +1 more source

Granulocyte-macrophage colony-stimulating factor for newly diagnosed glioblastoma

open access: yesNeoplasia: An International Journal for Oncology Research
Background: There is a clear need to improve the efficiency of therapeutic strategy for patients with newly diagnosed glioblastoma (GBM). The purpose of this study was to evaluate the feasibility of hypofractionated intensity-modulated radiation therapy (
Caineng Cao   +12 more
doaj   +1 more source

Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia

open access: yes, 1996
Granulocyte colony stimulating factor (G-CSF) treatment was successfully used in three preterm infants with alloimmune neonatal neutropenia (AINN). Two infants had persistent neutropenia despite treatment with intravenous immunoglobulin and random donor ...
Gray, PH   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy